부산대학교 도서관

Axel Couture; Eric Deniau; Pierre Grandclaudon

Tetrahedron. 53:10313-10330

Lishan Fang; Dane Ford-Roshon; Max Russo; Casey O’Brien; Xiaozhe Xiong; Carino Gurjao; Maximilien Grandclaudon; Srivatsan Raghavan; Steven M. Corsello; Steven A. Carr; Namrata D. Udeshi; James Berstler; Ewa Sicinska; Kimmie Ng; Marios Giannakis

Nature Communications, Vol 13, Iss 1, Pp 1-12 (2022)

Augustinianum. 8:203-204

A. COUTURE; E. DENIAU; P. GRANDCLAUDON

ChemInform. 28

Marios Giannakis; Lishan Fang; Dane Ford-Roshon; Max Russo; Casey O'Brien; Xiaozhe Xiong; Carino Gurjao; Maximilien Grandclaudon; Srivatsan Raghavan; Steven M. Corsello; Steven A. Carr; Namrata Udeshi; James Berstler; Ewa Sicinska; Kimmie Ng

Cancer Research. 82:PR009-PR009

L. Faucheux; M. Grandclaudon; M. Perrot-Dockès; P. Sirven; F. Berger; A.S. Hamy; V. Fourchotte; A. Vincent-Salomon; F. Mechta-Grigoriou; F. Reyal; A. Scholer-Dahirel; M. Guillot-Delost; V. Soumelis

OncoImmunology, Vol 8, Iss 9 (2019)

Gregorianum, 1964 Jan 01. 45(2), 390-390.

Grimaldi, A. ; Sauty, B. ; Grandclaudon, M. ; Boulch, M. ; Thaller, A. ; Hardy, A. ; Trichelair, P. ; Von Loga, K. ; Soumelis, V. ; Pierce, A. ; Hoffmann, C. ; Durand, E.

In Annals of Oncology September 2025 36 Supplement 2:S300-S300

Revue des Sciences philosophiques et théologiques, 1964 Apr 01. 48(2), 369-369.

Revue Biblique (1946-), 1952 Jan 01. 59(1), 91-93.

Angelicum, 1937 Jul 01. 14(3/4), 584-584.

S. Lerch; M. L. Lastel; C. Grandclaudon; C. Brechet; G. Rychen; C. Feidt

Journal of Animal Science. 93:4463-4472

C. Martinez-Cingolani; M. Grandclaudon; M. Jeanmougin; M. Jouve; R. Zollinger; V. Soumelis

Blood

Hoffmann C; Institut Curie, INSERM U932, Immunity and Cancer, Paris, France. caroline.hoffmann@curie.fr.; Institut Curie, Department of Surgical Oncology, Paris & Saint-Cloud, France. caroline.hoffmann@curie.fr.; Université Paris Sciences Lettres (PSL), Paris, France. caroline.hoffmann@curie.fr.; Noel F; Université de Paris, Institut de Recherche Saint-Louis, INSERM U976, Hôpital Saint-Louis, 75010, Paris, France.; Grandclaudon M; Institut Curie, INSERM U932, Immunity and Cancer, Paris, France.; Université Paris Sciences Lettres (PSL), Paris, France.; Massenet-Regad L; Université de Paris, Institut de Recherche Saint-Louis, INSERM U976, Hôpital Saint-Louis, 75010, Paris, France.; Université Paris-Saclay, Orsay, France.; Michea P; Institut Paoli Calmette, INSERM U1068-CNRS UMR7258-AMU UM105, Marseille, France.; Université Aix-Marseille, Marseille, France.; Sirven P; Institut Curie, INSERM U932, Immunity and Cancer, Paris, France.; Université Paris Sciences Lettres (PSL), Paris, France.; Faucheux L; Université de Paris, Institut de Recherche Saint-Louis, INSERM U976, Hôpital Saint-Louis, 75010, Paris, France.; Statistic and Epidemiologic Research Center Sorbonne Paris Cité, INSERM UMR-1153, ECSTRRA team, Paris, France.; Surun A; Institut Curie, SIREDO Cancer Center, Paris, France.; Lantz O; Institut Curie, INSERM U932, Immunity and Cancer, Paris, France.; Université Paris Sciences Lettres (PSL), Paris, France.; CIC IGR-Curie 1428, Center of Clinical Investigation, Paris, France.; Bohec M; Université Paris Sciences Lettres (PSL), Paris, France.; Institut Curie, NGS platform, Paris, France.; Ye J; City of Hope Comprehensive Cancer Center, Department of Immuno-Oncology, Duarte, CA, USA.; Guo W; City of Hope Comprehensive Cancer Center, Department of Immuno-Oncology, Duarte, CA, USA.; Rochefort J; Cimi Paris, INSERM U1135, and Hospital Pitié Salpêtrière, Odontology department, Université de Paris, Paris, France.; Klijanienko J; Université Paris Sciences Lettres (PSL), Paris, France.; Institut Curie, Department of pathology, Paris, France.; Baulande S; Université Paris Sciences Lettres (PSL), Paris, France.; Institut Curie, NGS platform, Paris, France.; Lecerf C; Université Paris Sciences Lettres (PSL), Paris, France.; Institut Curie, Department of Drug Development, and Innovation (D3i), Paris & Saint-Cloud, France.; Kamal M; Université Paris Sciences Lettres (PSL), Paris, France.; Institut Curie, Department of Drug Development, and Innovation (D3i), Paris & Saint-Cloud, France.; Le Tourneau C; Université Paris-Saclay, Orsay, France.; Institut Curie, Department of Drug Development, and Innovation (D3i), Paris & Saint-Cloud, France.; Institut Curie, INSERM U900, Saint-Cloud, France.; Guillot-Delost M; Institut Curie, INSERM U932, Immunity and Cancer, Paris, France.; Université Paris Sciences Lettres (PSL), Paris, France.; CIC IGR-Curie 1428, Center of Clinical Investigation, Paris, France.; Soumelis V; Institut Curie, INSERM U932, Immunity and Cancer, Paris, France. vassili.soumelis@aphp.fr.; Université Paris Sciences Lettres (PSL), Paris, France. vassili.soumelis@aphp.fr.; Université de Paris, Institut de Recherche Saint-Louis, INSERM U976, Hôpital Saint-Louis, 75010, Paris, France. vassili.soumelis@aphp.fr.; Institut Curie, Clinical immunology department, Paris, France. vassili.soumelis@aphp.fr.; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint-Louis, Laboratoire d'Immunologie, F-75010, Paris, France. vassili.soumelis@aphp.fr.; Université de Paris, Institut de Recherche Saint-Louis, INSERM U976, Hôpital Saint-Louis, 75010, Paris, France. vassili.soumelis@aphp.fr.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Karpf L; Institut Curie, PSL University, INSERM U932, Paris, France.; Université de Paris, Institut de Recherche Saint-Louis, INSERM U976, Paris, France.; Trichot C; Institut Curie, PSL University, INSERM U932, Paris, France.; Université de Paris, Institut de Recherche Saint-Louis, INSERM U976, Paris, France.; Immunology and Inflammation Therapeutic Area, Sanofi, Vitry-sur-Seine, France.; Faucheux L; Université de Paris, Institut de Recherche Saint-Louis, INSERM U976, Paris, France.; Université de Paris, Institut de Recherche Saint-Louis, INSERM UMR-1153, ECSTRRA Team, Paris, France.; Legbre I; Université de Paris, Institut de Recherche Saint-Louis, INSERM U976, Paris, France.; Grandclaudon M; Institut Curie, PSL University, INSERM U932, Paris, France.; Lahoute C; Immunology and Inflammation Therapeutic Area, Sanofi, Vitry-sur-Seine, France.; Mattoo H; Immunology and Inflammation Therapeutic Area, Sanofi, Cambridge, MA, USA.; Pasquier B; Immunology and Inflammation Therapeutic Area, Sanofi, Vitry-sur-Seine, France.; Soumelis V; Institut Curie, PSL University, INSERM U932, Paris, France. vassili.soumelis@aphp.fr.; Université de Paris, Institut de Recherche Saint-Louis, INSERM U976, Paris, France. vassili.soumelis@aphp.fr.; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint-Louis, Laboratoire d'Immunologie, Paris, France. vassili.soumelis@aphp.fr.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101661034 Publication Model: Electronic Cited Medium: Print ISSN: 2056-5968 (Print) Linking ISSN: 20565968 NLM ISO Abbreviation: Cell Discov Subsets: PubMed not MEDLINE

Noël F; Université de Paris, INSERM U976, Equipe labellisée par la Ligue Nationale contre le Cancer, F-75006 Paris, France.; Institut Curie, 26 rue d'Ulm, Paris, France.; INSERM U932, Immunity and Cancer, PSL Research University, Paris, France.; Massenet-Regad L; Université de Paris, INSERM U976, Equipe labellisée par la Ligue Nationale contre le Cancer, F-75006 Paris, France.; Université Paris-Saclay, Saint Aubin, 91190, France.; Carmi-Levy I; Institut Curie, 26 rue d'Ulm, Paris, France.; INSERM U932, Immunity and Cancer, PSL Research University, Paris, France.; Cappuccio A; Institut Curie, 26 rue d'Ulm, Paris, France.; INSERM U932, Immunity and Cancer, PSL Research University, Paris, France.; Grandclaudon M; Institut Curie, 26 rue d'Ulm, Paris, France.; INSERM U932, Immunity and Cancer, PSL Research University, Paris, France.; Trichot C; Université de Paris, INSERM U976, Equipe labellisée par la Ligue Nationale contre le Cancer, F-75006 Paris, France.; Institut Curie, 26 rue d'Ulm, Paris, France.; INSERM U932, Immunity and Cancer, PSL Research University, Paris, France.; Kieffer Y; Institut Curie, 26 rue d'Ulm, Paris, France.; INSERM U830, Stress and Cancer Laboratory, Equipe labellisée par la Ligue Nationale contre le Cancer, PSL Research University, Paris, France.; Mechta-Grigoriou F; Institut Curie, 26 rue d'Ulm, Paris, France.; INSERM U830, Stress and Cancer Laboratory, Equipe labellisée par la Ligue Nationale contre le Cancer, PSL Research University, Paris, France.; Soumelis V; Université de Paris, INSERM U976, Equipe labellisée par la Ligue Nationale contre le Cancer, F-75006 Paris, France. vassili.soumelis@aphp.fr.; Institut Curie, 26 rue d'Ulm, Paris, France. vassili.soumelis@aphp.fr.; INSERM U932, Immunity and Cancer, PSL Research University, Paris, France. vassili.soumelis@aphp.fr.; AP-HP, Hôpital Saint-Louis, Département d'Immunologie-Histocompatibilité, Paris, 75010, France. vassili.soumelis@aphp.fr.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

C M, Ghiciuc; D, Samson-Belei; C E, Lupuşoru; E, Bâcu; I M, Antonesi; O, Jerca; R, Lupuşoru; A, Couture; P, Grandclaudon

Annales pharmaceutiques francaises. 62(1)

Sirven P; INSERM Unit U932, Immunity and Cancer, Institut Curie, Paris, France.; Paris Sciences Lettres (PSL) University, Paris, France.; Center of Clinical Investigation, CIC IGR-Curie 1428, Paris, France.; Faucheux L; INSERM U976, Université de Paris, IRSLHôpital Saint Louis, 75006, Paris, France.; INSERM UMR1153, Université de Paris, ECSTRRA Team, 75006, Paris, France.; Grandclaudon M; INSERM Unit U932, Immunity and Cancer, Institut Curie, Paris, France.; Paris Sciences Lettres (PSL) University, Paris, France.; Center of Clinical Investigation, CIC IGR-Curie 1428, Paris, France.; Michea P; INSERM Unit U932, Immunity and Cancer, Institut Curie, Paris, France.; Paris Sciences Lettres (PSL) University, Paris, France.; Center of Clinical Investigation, CIC IGR-Curie 1428, Paris, France.; Vincent-Salomon A; Paris Sciences Lettres (PSL) University, Paris, France.; Diagnostic and Theranostic Medicine Division, Institut Curie, Paris, France.; Mechta-Grigoriou F; Paris Sciences Lettres (PSL) University, Paris, France.; Centre de Recherche, Stress and Cancer Laboratory, U830 Genetics and Biology of Cancers, INSERM, Institut Curie, Paris, France.; Scholer-Dahirel A; INSERM Unit U932, Immunity and Cancer, Institut Curie, Paris, France.; Paris Sciences Lettres (PSL) University, Paris, France.; Center of Clinical Investigation, CIC IGR-Curie 1428, Paris, France.; Guillot-Delost M; INSERM Unit U932, Immunity and Cancer, Institut Curie, Paris, France. maude.delost@curie.fr.; Paris Sciences Lettres (PSL) University, Paris, France. maude.delost@curie.fr.; Center of Clinical Investigation, CIC IGR-Curie 1428, Paris, France. maude.delost@curie.fr.; Soumelis V; INSERM Unit U932, Immunity and Cancer, Institut Curie, Paris, France. vassili.soumelis@aphp.fr.; Paris Sciences Lettres (PSL) University, Paris, France. vassili.soumelis@aphp.fr.; Center of Clinical Investigation, CIC IGR-Curie 1428, Paris, France. vassili.soumelis@aphp.fr.; INSERM U976, Université de Paris, IRSLHôpital Saint Louis, 75006, Paris, France. vassili.soumelis@aphp.fr.; Department of Immunology-Histocompatibility, AP-HP, Hôpital Saint-Louis, 75010, Paris, France. vassili.soumelis@aphp.fr.

Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE

Peper-Gabriel JK; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany.; Pavlidou M; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany.; Pattarini L; Institut de Recherches Servier, Center for Therapeutic Innovation Oncology, Croissy-sur-Seine, France.; Morales-Kastresana A; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany.; Jaquin TJ; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany.; Gallou C; Institut de Recherches Servier, Center for Therapeutic Innovation Oncology, Croissy-sur-Seine, France.; Hansbauer EM; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany.; Richter M; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany.; Lelievre H; Institut de Recherches Internationales Servier Oncology R&D Unit, Suresnes, France.; Scholer-Dahirel A; Institut de Recherches Internationales Servier Oncology R&D Unit, Suresnes, France.; Bossenmaier B; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany.; Sancerne C; Institut de Recherches Servier, Center for Therapeutic Innovation Oncology, Croissy-sur-Seine, France.; Riviere M; Institut de Recherches Servier, Center for Therapeutic Innovation Oncology, Croissy-sur-Seine, France.; Grandclaudon M; Institut de Recherches Servier, Center for Therapeutic Innovation Oncology, Croissy-sur-Seine, France.; Zettl M; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany.; Bel Aiba RS; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany.; Rothe C; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany.; Blanc V; Institut de Recherches Servier, Center for Therapeutic Innovation Oncology, Croissy-sur-Seine, France.; Olwill SA; Pieris Pharmaceuticals GmbH, Hallbergmoos, Germany.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Trichot, C. ; Faucheux, L. ; Karpf, L. ; Grandclaudon, M. ; Pattarini, L. ; Bagot, M. ; Mahévas, T. ; Jachiet, M. ; Saussine, A. ; Bouaziz, J.-D. ; Soumelis, V.

In Annales de Dermatologie et de Vénéréologie December 2020 147(12) Supplement:A123-A123